← FDA DRUG APPROVALS

FDA ANDA · ANDA202145

HYDROCORTISONE BUTYRATE

Sponsor: GLENMARK PHARMS LTD

APPLICATION
ANDA202145
TYPE
ANDA
ORIGINAL APPROVAL
2013-09-27
LATEST ACTION
2024-01-08
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

HYDROCORTISONE BUTYRATEDiscontinued
HYDROCORTISONE BUTYRATE 0.1% · CREAM · TOPICAL

Approval history

2024-01-08Labeling · Supplement 4 · standardAP
2013-09-27UNKNOWN · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →